BC

Birchview Capital Portfolio holdings

AUM $101M
This Quarter Return
+9.49%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$142M
AUM Growth
+$142M
Cap. Flow
+$2.61M
Cap. Flow %
1.84%
Top 10 Hldgs %
76.61%
Holding
63
New
3
Increased
5
Reduced
7
Closed
6
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
IMGN
26
DELISTED
Immunogen Inc
IMGN
$744K 0.53%
150,000
VTYX icon
27
Ventyx Biosciences
VTYX
$171M
$721K 0.51%
22,000
-23,000
-51% -$754K
BLUE
28
DELISTED
bluebird bio
BLUE
$678K 0.48%
98,000
APLS icon
29
Apellis Pharmaceuticals
APLS
$3.48B
$621K 0.44%
12,000
HALO icon
30
Halozyme
HALO
$8.56B
$569K 0.4%
+10,000
New +$569K
TSVT
31
DELISTED
2seventy bio
TSVT
$561K 0.4%
59,833
ISEE
32
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$535K 0.38%
25,000
SILK
33
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$529K 0.37%
10,000
ARVN icon
34
Arvinas
ARVN
$568M
$513K 0.36%
15,000
SLNO icon
35
Soleno Therapeutics
SLNO
$3.6B
$485K 0.34%
245,127
KNSA icon
36
Kiniksa Pharmaceuticals
KNSA
$2.48B
$449K 0.32%
30,000
PTGX icon
37
Protagonist Therapeutics
PTGX
$3.67B
$415K 0.29%
38,000
XENE icon
38
Xenon Pharmaceuticals
XENE
$2.98B
$394K 0.28%
10,000
TXG icon
39
10x Genomics
TXG
$1.74B
$364K 0.26%
+10,000
New +$364K
FOLD icon
40
Amicus Therapeutics
FOLD
$2.34B
$342K 0.24%
28,000
-10,000
-26% -$122K
KROS icon
41
Keros Therapeutics
KROS
$618M
$336K 0.24%
+7,000
New +$336K
SRPT icon
42
Sarepta Therapeutics
SRPT
$1.78B
$324K 0.23%
2,500
XNCR icon
43
Xencor
XNCR
$580M
$320K 0.23%
12,300
KALV icon
44
KalVista Pharmaceuticals
KALV
$678M
$270K 0.19%
40,000
NKTR icon
45
Nektar Therapeutics
NKTR
$568M
$267K 0.19%
118,000
-10,000
-8% -$22.6K
CGEM icon
46
Cullinan Oncology
CGEM
$445M
$265K 0.19%
25,114
BCRX icon
47
BioCryst Pharmaceuticals
BCRX
$1.74B
$230K 0.16%
20,000
IFRX icon
48
InflaRx
IFRX
$108M
$217K 0.15%
70,000
GTHX
49
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$217K 0.15%
40,000
GOSS icon
50
Gossamer Bio
GOSS
$562M
$215K 0.15%
99,088
-60,000
-38% -$130K